|
|
Article: Fatal cases of CJD linked to human growth hormone.(Creutzfeldt-Jakob disease)(Brief Article)
- Article from:
- Pain & Central Nervous System Week
- Article date:
- July 22, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 JUL 22 - (NewsRx.com & NewsRx.net) -- Further cases of Creutzfeldt-Jakob (CJD) disease could arise as a result of human growth hormone treatment even after low doses, suggests research in the Journal of Neurology Neurosurgery and Psychiatry.
A rare and usually fatal disease of the brain characterized by progressive dementia and gradual loss of muscle control, CJD occurs most often in middle age.
Dutch researchers report on the case of a man who developed CJD 38 years after receiving human derived growth hormone.
A 47-year-old man was given only a low dose as part of a diagnostic procedure, rather than being given full treatment, which may ...